Jenburkt Pharmaceuticals Fundamental Analysis
JENBURPH
1003.922.90 (-2.23%)
Last updated on 11 Sep, 2026 | 15:59 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Jenburkt Pharmaceuticals Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Jenburkt Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Jenburkt Pharmaceuticals Associated Pages
- Jenburkt Pharmaceuticals
Share Price - Jenburkt Pharmaceuticals
Share Price chart - Jenburkt Pharmaceuticals
Technical Analysis - Jenburkt Pharmaceuticals
Peer Comparison - Jenburkt Pharmaceuticals
Share Price History - Jenburkt Pharmaceuticals
Dividend - Jenburkt Pharmaceuticals
Board of Directors - Jenburkt Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in JENBURPH
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC